Quick Answer
Healthcare Triangle, Inc. reported Diluted EPS of $1.13 per share (loss) for fiscal year 2024.
Healthcare Triangle, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$1.13 | +45.7% |
| 2023 | -$2.08 | +20.9% |
| 2022 | -$2.63 | -1202.0% |
| 2021 | -$0.20 | -340.5% |
| 2020 | $0.08 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.42 | +99.2% | +27.6% |
| June 30, 2025 | -$0.58 | +99.2% | -241.2% |
| March 31, 2025 | -$0.17 | +59.5% | +99.7% |
| September 30, 2024 | -$54.78 | -12073.3% | +22.5% |
| June 30, 2024 | -$70.72 | -16738.1% | -16738.1% |
| March 31, 2024 | -$0.42 | +46.8% | +6.7% |
| September 30, 2023 | -$0.45 | — | -7.1% |
| June 30, 2023 | -$0.42 | -4100.0% | +46.8% |
- Healthcare Triangle, Inc. showed an increase of +45.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2024 period, Healthcare Triangle, Inc.’s diluted eps has declined by 1445.2% (from $0.08 per share to $1.13 per share (loss)).
- The most recent figure is from Healthcare Triangle, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: